<--- Back to Details
First PageDocument Content
Quality / Validation / Validity / Qualified Person / Good distribution practice / Systems engineering process / Science / Evaluation / Form / Pharmaceuticals policy / Pharmaceutical industry / Clinical research
Date: 2013-10-09 09:37:38
Quality
Validation
Validity
Qualified Person
Good distribution practice
Systems engineering process
Science
Evaluation
Form
Pharmaceuticals policy
Pharmaceutical industry
Clinical research

Microsoft Word - QPAssociation_Comment_Draft EU GDP Guide.doc

Add to Reading List

Source URL: ec.europa.eu

Download Document from Source Website

File Size: 82,61 KB

Share Document on Facebook

Similar Documents

FINECURE PHARMACEUTICALS LIMITED NOMINATION AND REMUNERATION POLICY I. PREAMBLE

DocID: 1vhvU - View Document

For over 20 years, Health Policy Associates has been providing practical and highly efficient consulting solutions to companies involved in developing new medical device technologies, pharmaceuticals and biologics. Clin

DocID: 1vdpM - View Document

FINECURE PHARMACEUTICALS LIMITED POLICY ON ARCHIVAL OF DOCUMENTS 1. PREAMBLE The Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR") came into force fr

DocID: 1v1UD - View Document

FINECURE PHARMACEUTICALS LTD. CIN: U24230GJ2005PLC045724 CORPORATE SOCIAL RESPONSIBILITY POLICY Registered Office:

DocID: 1uqeg - View Document

Privacy Policy Revised as of April 4, 2018 Welcome to www.minivelle.com, a web site owned by Noven Pharmaceuticals, Inc. (Noven, our, or we). This Privacy Policy is designed to tell you about our practices regarding coll

DocID: 1un1u - View Document